Corrigendum to “The novel mineralocorticoid receptor antagonist finerenone in diabetic kidney disease: Progress and challenges” [Metabolism 65 (2016) 1342–1349]

Pingping Yang; Tianlun Huang; Gaosi Xu

首页> 外文期刊>Metabolism: Clinical and Experimental >Corrigendum to “The novel mineralocorticoid receptor antagonist finerenone in diabetic kidney disease: Progress and challenges” [Metabolism 65 (2016) 1342–1349]

【24h】

Corrigendum to “The novel mineralocorticoid receptor antagonist finerenone in diabetic kidney disease: Progress and challenges” [Metabolism 65 (2016) 1342–1349]

机译：“糖尿病肾疾病中新型矿物皮质激素受体拮抗剂Finerenone的勘探：进展和挑战”[代谢65（2016）1342-1349]

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Metabolism: Clinical and Experimental》 |2018年第2018期|共1页
作者
Pingping Yang; Tianlun Huang; Gaosi Xu;
展开▼
作者单位

Department of Nephrology the Second Affiliated Hospital of Nanchang University;

Department of Nephrology the Second Affiliated Hospital of Nanchang University;

Department of Nephrology the Second Affiliated Hospital of Nanchang University;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病;
关键词

相似文献

外文文献
中文文献
专利

1. Corrigendum to “The novel mineralocorticoid receptor antagonist finerenone in diabetic kidney disease: Progress and challenges” [Metabolism 65 (2016) 1342–1349] [J] . Pingping Yang, Tianlun Huang, Gaosi Xu Metabolism: Clinical and Experimental . 2018,第期

机译：“糖尿病肾疾病中新型矿物皮质激素受体拮抗剂Finerenone的勘探：进展和挑战”[代谢65（2016）1342-1349]
2. Finerenone: third-generation mineralocorticoid receptor antagonist for the treatment of heart failure and diabetic kidney disease [J] . Liu Licette C. Y., Schutte Elise, Gansevoort Ron T., Expert opinion on investigational drugs . 2015,第8期

机译：Finerenone：第三代盐皮质激素受体拮抗剂，用于治疗心力衰竭和糖尿病肾病
3. FINERENONE Mineralocorticoid receptor (MR) antagonist Treatment of chronic kidney disease/diabetic nephropathy Treatment of heart failure [J] . Cole P. Drugs of the Future . 2015,第12期

机译：FINERENONE盐皮质激素受体（MR）拮抗剂治疗慢性肾脏疾病/糖尿病肾病心力衰竭
4. Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease [O] . Nina Vodošek Hojs, Sebastjan Bevc, Robert Ekart, 2021

机译：矿物质皮质激素受体拮抗剂在糖尿病肾脏疾病中
5. Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Protects Against Acute Kidney Injury–Mediated Chronic Kidney Disease [O] . Lionel Lattenist, Sebastian M. Lechner, Smail Messaoudi, 2017

机译：非甾体Mineralocortoidoidoid受体拮抗剂Finerenone保护急性肾损伤介导的慢性肾病

Corrigendum to “The novel mineralocorticoid receptor antagonist finerenone in diabetic kidney disease: Progress and challenges” [Metabolism 65 (2016) 1342–1349]

著录项

相似文献

相关主题

期刊订阅